Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

The Inflation Reduction Act of 2022 marked a significant shift in US health care policy, granting the Centers for Medicare and Medicaid Services (CMS) the authority to establish a program to negotiate ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

Medicare officials will soon unveil prices for the first drugs subject to the 2022 Inflation Reduction Act's price controls. The government says it has "negotiated" with drugmakers to arrive at ...

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...

However, there has been one notable exception: the Medicare Drug Price Negotiation Program — although they’re leaving room for some potential changes. The program, created under the Inflation ...

Drug company Merck is suing the United States government in an attempt to undercut drug price negotiations laid out by the Biden administration's Inflation Reduction Act (IRA). The crux of Merck's ...

The Centers for Medicare and Medicaid Services is moving forward with Medicare drug price negotiations under the Trump administration, although it said it is seeking to bring "greater transparency ...

Novo Nordisk's NovoCare will now provide uninsured or underinsured patients access to Wegovy for just $499 per month—less ...

From the first 10 drugs already negotiated under ... pharma lobby have been fighting against the negotiation program — calling it a form of “price setting” — the operational focus has ...

A federal court rejected Novartis Pharmaceuticals’, a unit of Novartis AG (NYSE:NVS) legal challenge to the Medicare Drug ...

Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...